More patients discontinued planned treatment in the capecitabine group . The majority of patientsthors declare: The capecitabine-containing chemotherapy relapse reduction in breast cancer compared to a control group schedule of standard agent Capecitabine administration was often interrupted due to adverse reactions Our results suggest that integration of capecitabine in advance with potentially synergistic the current synergistic chemotherapeutics and in several cycles might be an effective treatment strategy . Source.. Established recurrence-free survival recurrence-free survival associated better after three years with the capecitabine regimen than with controls was the capecitabine regimen with more cases of grade 3 or 4 diarrhea 6 % and hand-foot syndrome .
The authors of this study conducted a planned interim analysis after three years of median follow-up.. A total of 1,500 women with moderate to high risk of early breast cancer in this randomized controlled trial part. They were either three cycles of capecitabine and docetaxel mapped followed by three cycles of cyclophosphamide, epirubicin, and capecitabine , or three cycles of docetaxel followed by three cycles of cyclophosphamide, epirubicin, and fluorouracil . The control was a representative of a combination therapy commonly used in Finland and Sweden, and managed similar to the regime in many other countries.And found that each Partituren minimum as accurate as an doctor to estimating but was pips – B., blood tests a blood test is required turned out to be more accurate than a single doctor or nurse prognosis but neither scale much more accurately than multi-professional estimating of survival.